A different look at corticosteroids.
Zoorob RJ, Cender D.
Am Fam Physician. 1998 Aug;58(2):443-50.
Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): Epidemiology, Pathogenesis, Presentation and Prognosis.
Anand AC, Nandi B, Acharya SK, Arora A, Babu S, Batra Y, Chawla YK, Chowdhury A, Chaoudhuri A, Eapen EC, Devarbhavi H, Dhiman R, Datta Gupta S, Duseja A, Jothimani D, Kapoor D, Kar P, Khuroo MS, Kumar A, Madan K, Mallick B, Maiwall R, Mohan N, Nagral A, Nath P, Panigrahi SC, Pawar A, Philips CA, Prahraj D, Puri P, Rastogi A, Saraswat VA, Saigal S, Shalimar, Shukla A, Singh SP, Verghese T, Wadhawan M; INASL Task-Force on Acute Liver Failure.
J Clin Exp Hepatol. 2020 Jul-Aug;10(4):339-376. doi: 10.1016/j.jceh.2020.04.012. Epub 2020 Apr 28.
ACR Appropriateness Criteria® Abnormal Liver Function Tests.
Expert Panel on Gastrointestinal Imaging; Arif-Tiwari H, Porter KK, Kamel IR, Bashir MR, Fung A, Kaplan DE, McGuire BM, Russo GK, Smith EN, Solnes LB, Thakrar KH, Vij A, Wahab SA, Wardrop RM 3rd, Zaheer A, Carucci LR.
J Am Coll Radiol. 2023 Nov;20(11S):S302-S314. doi: 10.1016/j.jacr.2023.08.023.
Antithyroid Agents.
[No authors listed]
2014 Feb 16. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–.
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial.
Cho J, Kim HS, Ku BM, Choi YL, Cristescu R, Han J, Sun JM, Lee SH, Ahn JS, Park K, Ahn MJ.
J Clin Oncol. 2019 Aug 20;37(24):2162-2170. doi: 10.1200/JCO.2017.77.3184. Epub 2018 Jun 15.
Severe and fulminant hepatitis of indeterminate etiology in a Japanese center.
Fujiwara K, Yasui S, Nakano M, Yonemitsu Y, Arai M, Kanda T, Fukuda Y, Oda S, Yokosuka O.
Hepatol Res. 2015 Oct;45(10):E141-9. doi: 10.1111/hepr.12483. Epub 2015 Feb 26.
Regorafenib induced severe toxic hepatitis: characterization and discussion.
Sacré A, Lanthier N, Dano H, Aydin S, Leggenhager D, Weber A, Dekairelle AF, De Cuyper A, Gala JL, Humblet Y, Sempoux C, Van den Eynde M.
Liver Int. 2016 Nov;36(11):1590-1594. doi: 10.1111/liv.13217. Epub 2016 Sep 6.
COVID-19-induced autoimmune thyroiditis: Exploring molecular mechanisms.
Mohammadi B, Dua K, Saghafi M, Singh SK, Heydarifard Z, Zandi M.
J Med Virol. 2023 Aug;95(8):e29001. doi: 10.1002/jmv.29001.
Early therapeutic plasma exchange may improve treatment outcomes in severe acute toxic Hepatitis.
Berber I, Cagin YF, Erdogan MA, Ataman E, Gozukara H, Erkurt MA, Yildirim O, Kuku İ, Kaya E, Bilgic Y, Sarici A, Bicim S, Polat A.
Transfus Apher Sci. 2021 Oct;60(5):103250. doi: 10.1016/j.transci.2021.103250. Epub 2021 Aug 17.
Hepatitis D virus (HDV) infection in severe forms of liver diseases in north India.
Irshad M, Acharya SK.
Eur J Gastroenterol Hepatol. 1996 Oct;8(10):995-8. doi: 10.1097/00042737-199610000-00011.
